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Lumbar sympathectomy
No objective evidence supports the use of lumbar sympathectomy in the treatment ofIC.25
Neither resting nor exercise blood flow is increased by the performance of a sympathectomy.26
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B 4.5 Comparison of Therapeutic Options for Intermittent Claudication
There is overwhelming evidence that walking capacity is increased by exercise. The timing and
type of exercise has been extensively studied, and supervised frequent exercise sessions offer sig-
nificant benefit in increasing claudication distance (see B 4.1.2, Basic Treatment, p S80).1 The
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question as to whether exercise is superior to limited interventions such as balloon angioplasty
(PTA) is more controversial. In a study from the United Kingdom, in which patients were fol-
lowed-up for 6 years, ABPI increased during the first 15 months after PTA; however, more sig-
nificant changes in walking distances were seen in the exercise group. At 6 years' follow-up,
there were no differences between groups- (see also Recommendation 29, p S85). The loss of
the initial advantage of PTA was attributable to restenosis of the dilated segment, whereas those
treated conservatively had a steadily increasing benefit of exercise. The later loss of advantage of
exercise was probably due to lack of adherence to the exercise program. The best effect of exer-
cise was found in patients with disease confined to the superficial femoral artery, in contrast to
PTA, which has the best effect in iliac lesions.
In a second British study screening 600 patients with IC during follow-up of 6 months, PTA
patients benefited more in walking distance and ABPI than those randomized to exercise.f The
report on quality oflife recorded a better response after PTA than after exercise. However,
when the same group reported their results after 2 years' follow-up, there were no significant
differences in patient-reported walking distances, exercise treadmill distances (to onset of pain or
maximal distance), ABPI, or quality of Iife.? Only the number of patent arteries favored PTA.
Thus, two randomized trials with extended follow-up showed no advantage to PTA. However,
in these two trials, the predominant lesions were in the femoropopliteal segment, not the iliac
arteries, where PTA results are much better (over 20% better patency).
Another study has shown that unsupervised exercise programs are unlikely to significantly
improve the patient's quality oflife compared with interventional treatrnent.f Using the
McMaster Health Index Questionnaire, an Italian study showed that the quality of life was
impaired in patients suffering from IC; however, this impairment correlated poorly to the
reduced exercise capacity.? A randomized study compared percutaneous transluminal angioplasty
(n = 20) with a supervised program of dynamic leg exercises (n = 16).7 Constant-load treadmill
testing was performed at 3, 6, 9, and 12 months to evaluate change in pain-free and maximal
walking distances. It was found that, after angioplasty, mean ABPI were significantly improved,
but only at the 3-month point was maximum walking distance improved over baseline. In con-
trast, in the exercise group, despite no improvement in the ABPI, maximal and pain-free walk-
ing distances were progressively increased at each follow-up, with significant increases at 6, 9,
and 12 months. For example, pain-free walking distance increased by 296% and maximum walk-
ing distance by 442% at the 12-month point in the exercise-trained group.
Care must be taken when reviewing reports of comparative trials of PTA. Many studies report
the results of the treatment of the most favorable lesions, and these may not always be extrapo-
lated to all lesions in a similar area. The breadth of vascular disease frequently makes compara-
tive study groups less than equal. The results of PTA are frequently reported for claudicators,
whereas surgical results often include patients with CLI. These facts must be remembered when
reviewing the literature and choosing the best treatment for an individual patient. Calls for
appropriate long-term randomized control trials have been made.f Such studies should include
assessment of both walking distance and quality of life.
A further question is whether there is a functional benefit of surgery in patients with IC, In a
study presented in 1993, it was found that after 6 weeks there was an improvement in resting
ABPI, as well as of treadmill walking time and of self-reported community-based walking
ability? Another study evaluating functional outcome included 68% inflow procedures, with the
remaining being infrainguinal operations, of which 93% were femoropopliteal bypass grafts. It
was found that the procedure gave optimal results if restricted to patients younger than 70
years, who were nondiabetic patients, and in those in whom a normalization of the ankle pres-
sure could be anticipated.U' Interestingly, when functional status was assessed postrevasculariza-
tion, this study showed that 17% of patients were dissatisfied with their outcome. Of these,
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approximately 50% had a normal postoperative ABPI. This implies that surgical morbidity, even
without complications, is important in patient satisfaction-independent of the success of the
revascularization.
Lundgren et alll conducted a randomized, controlled trial comparing the effects of (1) periph-
eral bypass surgery alone; (2) surgery followed by 6 months of supervised exercise training with
dynamic leg exercises; and (3) 6 months of supervised exercise training alone in 75 patients with
claudication. Constant-load treadmill testing was used in this study. At 13 months after random-
ization, walking ability was improved in all three groups. In this study, the most effective treat-
ment for improving functional status was exercise training plus surgery. The changes in maximal
walking distance were 173% for the operated group, 263% for the group that received both
therapies, and 151% for the exercise-trained group. The authors found that although all surgi-
cally treated patients increased their walking distance more than patients who received only
exercise training, they also had a greater rate of complications than the exercise group.
In another study, surgery was compared with PTA.l2 This study included not only patients with
IC, but also a small proportion of patients with severe ischemia. This randomized, controlled
trial was not able to show a significant difference between bypass surgery and angioplasty, but,
given the sample size, it has only a power of 0.21 to detect a difference of 50%. For detecting
differences in subgroups, the power was even lower. Furthermore, only patients who were con-
sidered to have lesions appropriate for PTA were entered in this trial. Today, these cases would
not be considered candidates for surgery but rather would be referred for PTA. The I-year
result of PTA versus surgery was also evaluated in 102 patients over a 6-year period. 13 It was
found that only 5% of tile patients screened for the study were suitable for both kinds of treat-
ments and could therefore be included. Thus, these were almost all patients that today would be
considered for PTA as primary invasive treatment. The success and complication rates were the
same in both groups, but the hospital stay was significantly shorter for the PTA patients. This
points out the difficulties in conducting a randomized control trial comparing two modalities
that are suited for quite different lesions.
The most important femoropopliteal study is a decision and cost-effectiveness analysis of revas-
cularization procedures for femoropopliteal disease by Hunink and colleagues.14 The authors
used a literature review of mortality, morbidity, patency, and cost data as a source. There were
4,800 PTAs and 4,511 bypass operations. They developed a decision analytic model to examine
the choice between bypass surgery and PTA for lesions amenable to either procedure. Outcomes
measured included 5-year patency, QALY, lifetime costs, and incremental cost-effectiveness
ratios. Six treatment strategies were analyzed: (1) no treatment; (2) initial PTA with no further
revascularization; (3) initial PTA with subsequent PTA; (4) initial PTA with subsequent bypass
surgery; (5) bypass surgery followed by no further therapy; (6) bypass surgery followed by graft
revision. The results showed that for a 65-year-old man with disabling claudication and a
fcmoropopliteal stenosis or occlusion, the initial PTA strategy increased QALY by 2 to 13
months and resulted in decreased lifetime expenditures as compared with bypass surgery.
Sensitivity analysis showed that when the 5-year patency of PTA exceeds 30%, PTA is the pre-
ferred initial invasive strategy. The authors concluded that PTA is the preferred initial strategy in
patients with disabling claudication and femoropopliteal stenosis or occlusion.
To evaluate the results of the various procedures, reporting standards are important, including
operative morbidity, mortality, and patency figures that do not exclude initial failures and identi-
fy reintervention as secondary patency. IS The interpretation of results of reconstruction is com-
plicated by the mixture of patients included in the series, which included not only claudication
as an indication, but more frequently combinations series of severe ischemia and IC.
Furthermore, in the comparison of various treatment modalities, combinations of proximal and
distal reconstruction are described.
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Descriptive series of infrainguinal bypass for claudication with a distal anastomosis above the
knee, but including all kinds of autologous or synthetic materials, claim a 5-year patency of 60%
to 70%.16,17 It therefore could be assumed that a synthetic graft (ePTFE or glutaraldehyde-
treated HUV) perform equally well as the autologous vein. This has lead to the conclusion that
one could advocate a prosthetic conduit, specifically PTFE, for an AJ( reconstruction.lf This is
not supported by other studies, however.l? If the procedure has to be extended below the knee,
the use of autologous vein is strongly recommended. 20 It is unfortunate that surgical studies
reviewed did not include exercise therapy as one of the treatment options. However, the meta -
analysis cited will be helpful in choosing between different forms of interventional therapy.
Although not a comparative study, the meta-analysis by Hunink et al21 at least yields patency
data for the procedures performed to relieve Ie caused by atherosclerosis in the femoropopliteal
region (for further results, see B 4.3 Endovascular Procedures, p 597). Applied across the board,
this treatment strategy of initial PTA provides quality-of-life and lifetime expenditure advantages
over a strategy of initial bypass surgery (see also Reconunendation 31, 598; Recommendation
34, p 5104) .
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